A specialty biopharmaceutical business focused on treatments for rare diseases and specialty conditions, with products spanning immunology, hematology, neuroscience, and genetic disorders. The company built a portfolio of high-margin therapies including treatments for ADHD and hereditary angioedema ...
This page tracks all publicly disclosed congressional trades in Shire plc Ordinary Shares (SHPGF), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 0 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-31 | Greg Gianforte | buy | $50K – $100K |